In this economy?! 👀 📉

January 6, 2022 Good morning traders! Welcome back to The Daily Setup. Markets were in the red after the release of the Fed minutes. Here’s what’s on the docket today: - Fed minutes and the Jobs report - Sony and Chevy show off their EVs - BTCS pays its dividend in bitcoin Let’s get to work. Nick How’d the markets look? Market Outlook 👀 📉 Mainz, EVs, and the Economy BIGGEST MOVER The Colon Ryan of CRC Detection Shares of Mainz Biomed (MYNZ), a molecular genetics diagnostic company, rallied to the tune of [46.39%]( during Wednesday’s trading session. The company announced that they had acquired exclusive rights to Novel mRNA Biomarkers via a technology rights agreement with Socpra Sciences Santé Et Humaines. This agreement will mean that Mainz will be the only ones able to access [Socpra’s portfolio of novel mRNA biomarkers](, which they plan to use for potential future integration into ColoAlert. - ColoAlert is a simple-to-administer test that is used for detecting colorectal cancers (CRCs) and has a âsensitivity and specificity nearly as high as the invasive colonoscopy.â - mRNA biomarkers have shown promising results in detecting pre-cancerous polyps and early-stage CRCs. - CRCs are [the second most lethal cancer]( in the U.S. and Europe but have survival rates above 90% with early detection. Mainz Biomed [finished 2021 up 4%](, but Wednesday’s announcement could be the catalyst needed for continued growth throughout 2022. MYNZ started trading on the Nasdaq on November 8, 2021 and has traded in a range from $7.80-$11.45 up until Tuesday. With yesterday’s news taking the stock as high as $18.68, I would like to see a bit of a retracement before thinking about putting on a long position. In this economy?! – Jobs and Fed minutes It was economics day yesterday at school, as the releases of the ADP jobs report and Fed minutes bookended the day. ADP released their December jobs report before the bell on Wednesday, and boy did it not disappoint. [The economic report which measures](, “the change in employees on private companies’ payrolls,” came in at 807K, more than doubling economists’ estimates of 400K, and continuing to prove that economists are just sh*tty meteorologists. - Companies with 500+ employees accounted for [48% of December’s growth]( by adding 389K jobs. - Leisure and hospitality related businesses led the way with gains of 246K jobs. - [ADP’s chief economist Nela Richardson]( said, âDecember’s job market strengthened as the fallout from the Delta variant faded and Omicron’s impact had yet to be seen.â In other words, next month’s numbers will probably be a whole lot worse. Right on schedule, the Fed’s meeting minutes from the mid-December meetings were released near the close of trading. The minutes indicated [that officials believe]( that higher inflation, which apparently was not transitory, will lead to raising the federal funds rate and shrinkage of the balance sheet sooner than expected. [Cue George Costanza](. - The three major indices, which were already down on the day, continued their declines after the release - Economists and overnight swaps markets suggest that we will likely see [a 25 basis point rate hike]( as soon as March. The ADP report comes two days before the Bureau of Labor Statistics (BLS) releases their non-farm payrolls and unemployment report numbers before Friday’s open. These numbers can differ drastically when compared to the ADP report, so it’s not a foregone conclusion that we’ll see positive results come Friday. If I trade Friday’s number, I’ll keep my size small and will be patient. It’s often the second move that proves to be the most profitable. Sony and Chevy Hit the Road It’s that time of the year and all the high rollers in consumer technology have converged on Las Vegas for CES. Some of the biggest names like Microsoft and Amazon have [opted out]( this year, making this year’s expo more of an electric vehicle showcase than anything. But don’t worry, execs still flew in on their private jets. Two of the biggest names to roll the dice on their entry to EVs this week were Chevy and *checks notes* Sony. You heard that right, the renowned game-box maker apparently has their own aspirations of scoring big, revealing their [Vision S-02 prototype](. Who knows, maybe the PS6 is going to have off-roading capabilities. - The Silverado RST [is set to hit the market](in Spring 2023. Late to the game? Yes, but looks like GM is set to make up for lost time, as GM plans to launch 30 EVs by 2030. A fully electric Silverado is huge news for GM because not only is the Silverado one of America’s most popular trucks, it’s one of the most [popular vehicles period.]( - Sony stock was up Wednesday after announcing their own entry to the EV market through their operating company [Sony Mobility]( inc. While this is clearly their EV play, they’ve also been developing technologies that coincide perfectly with the market such as [sensors and camera monitoring.]( Well, the automotive renaissance seems to truly be upon us. It was only a matter of time before traditional car manufacturers turned toward EVs, but as newer companies like Rivian and unsuspecting companies like Sony throw their hats in the ring, competition is only going to get more intense. On the plus side, competition will be great for consumers and probably spur adoption. Of course some will be left in the lurch but those who find success early might make it out. Also, let’s face it, [Tesla]( won’t be going anywhere. BTCS Bividend Bonzana Token Talk Big news in the crypto world as blockchain infrastructure developer BTCS becomes the first Nasdaq-listed company to offer a Bitcoin dividend to its shareholders. The “cleverly” named Bividend is one step in BTCS’ goals of pushing [crypto adoption and financial freedom](. Seeing as their stock soared 43.89% after this announcement, it looks like they might be on the way to pulling that off (while conveniently building their shareholder base). - BTCS is aiming to pay shareholders a [5 cent dividend]( (in Bitcoin of course) for holders who decide to opt in. They expect to pay based on the price of BTC on the ex-dividend date of March 16th. - The bividend seems to have been one of BTCS’ long-term goals on their roadmap as they actually registered the domain []( all the way back in February of 2015. Kudos to the internet sleuths who saw this coming. This announcement from BTCS is yet another step on the road to widespread crypto adoption. It’s too early to tell if the notion of a “dividend” is to become a trend amongst other blockchain-focused companies and beyond, but it definitely seems to be working for BTCS in the immediate-term. What this does show for certain is there is enough interest in blockchain infrastructure for BTCS to have enough success to even distribute dividends in the first place. Perhaps the bividend is more than just clever branding and more a sign of the times. To Health and Happiness Rumor has it ^IBM’s original solution for Watson Health A recent report by Axios has alleged that IBM is shopping around Watson Health for $1B in an effort to remove the $4B tumor that it’s been on IBM’s portfolio. IBM has refused to comment on the matter, but considering that Watson Health was bringing in $1B of revenue and [[still](]([isn’t profitable](, it would be questionable if they didn’t try to sell it. - The [$4B]( that IBM spent on the venture consisted of: $2.6B for Truven Health Analytics, nearly $1B for Merge Healthcare, and $230M for Phytel. All three of these businesses no longer fit into IBM’s new direction for their portfolio. - IBM has involved [BofA Securities]( in conducting the sale, as final bids were due this past Tuesday. Rumor has it that potential buyers include multiple private equity firms and one strategic buyer. Neither IBM nor BofA have made any official statements on the potential sale of Watson Health but CEO Arvid Krishna did mention in an interview with Axios in late 2021 that perhaps the technology corporation had been a little “too optimistic” about their healthcare play. That’s probably the closest to an omission of failure that we’ll ever see from a CEO so that definitely gives credence to the theory that Watson Health is about to hit the bargain bin. Of course this doesn’t spell doom for IBM, really they’re cutting the chaff in their effort to streamline for the cloud and position for the future. Link Roundup 📿 Other News Other News Link Roundup - Telephone Picks Up – AT&T Posts Monster Gains in Subscribers ([link]() - The Tour de Nowhere Good – Peloton Keeps Going Lower ([link]() - You Don’t Have to Tell Me Twice – Hong Kong Bans Flights From 8 Countries ([link]() - Not What the Colonel Ordered – Beyond Fried Chicken Coming to KFC ([link]() Looking forward to 2023, [via @wallstmemes]( [Image] RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Unsubscribe from all RagingBull emails]( Questions or concerns about our products? Call or text us on your mobile: 1.800.123.4567 © Copyright 2020, [RagingBull]( - [Refund Policy]( - [Privacy Policy]( - [Terms & Conditions]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [Unsubscribe from all RagingBull emails](